Similar results by Wu et al. [121] confirmed that BDNF overexpression enhances the therapeutic potential of the NSC transplantation strategy in a transgenic mouse model of AD transplanted into the hippocampus of 16-month-old APP transgenic rodents, compared to transplantation of NSCs without BDNF overexpression. This evidence concerns the gene APP and Alzheimer disease.